✦ LIBER ✦

Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease

✍ Scribed by Dickerson, Bradford C. ;Sperling, Reisa A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease-Modifying Therapies in Alzheimer

✍ Dr Michael Hüll, Mathias Berger, Michael Heneka 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 183 KB

Neuroimaging outcomes in clinical trials

✍ Giovanni B. Frisoni; A. Delacourte 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 112 KB

New approaches to disease modifying ther

✍ Ravindranath, V. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Biomarker utility in Alzheimer's disease

✍ Soares, Holly D.; Lovestone, Simon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Challenges to demonstrating disease-modi

✍ Jeffrey L. Cummings 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Preclinical and clinical challenges in t

✍ Carol A Scorer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB